According to the head of the Department of Infectious Diseases of the Bogomolets National Medical University, this is an inactivated (contains an inactive, “killed” virus) vaccine CoronaVac / Sinovac Biotech.
“Everything is just being studied, but I absolutely agree that the best safety profile we have is CoronaVac, Chinese vaccines. They say they are not effective / effective … Listen: China re-vaccinated – everything is quiet calmly. Indonesia has been re-vaccinated. If I’m not mistaken, so is Singapore. Therefore, do not … “- said Golubovskaya.
The infectious disease doctor emphasized that antibodies are not all immunity.
“Everyone has already learned that there is T-cell immunity. So the level of antibodies and the level and strength of T-cell immunity do not always correlate. We just have no other mechanism. We only have a mechanism to detect antibodies. That’s all,” she explained. medic.
She also drew attention to the article of the President of the European Federation of Immunological Societies (EFIS), Professor Andreas Radbruch, that antibody titers cannot be the same six months later as they were at the peak of the disease or after the disease – they fall and remain at the level of 10-20 % of the original.
Answering the question of the presenter why then CoronaVac do not want to be recognized in some EU countries, Golubovskaya explained this by an economic, not a medical reason.
“This is pure money, this is the protection of their markets, and that’s all. They protect their markets – there is very little about medicine there. In general, there is very little in this whole coronavirus story about medicine. And I think that sooner or later this will be assessed,” the doctor spoke up.
– .
